The largest database of trusted experimental protocols

4 protocols using rnase a inhibitor

1

Purifying Extracellular Vesicles by Freeze-Thaw and Enzyme Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
To remove RNAs or proteins of EVs, the EVs were put in liquid nitrogen for 1-2 minutes, and then dissolved in 37°C water bath for 2-3 minutes. EVs were underwent five freeze-thaw cycles as described previously (56 (link)). Thereafter, the EVs were treated with RNase A (Takara, 100 μg/mL, 37°C, 30 min) to degrade RNAs in EVs, followed by incubating with RNase A inhibitor (Takara, 2,000 units/mL, 37°C, 30 min) to inactivate RNase A. To degrade proteins, EVs were treated with proteinase K (Sigma, 25 μg/mL, 37°C, 30 min), followed by heating at 95°C for 5min to inactivate proteinase K.
+ Open protocol
+ Expand
2

RNA Cleavage Assay with Tospovirus N Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA cleavage reactions were performed by incubating DIG-11-UTP-labeled RNA transcripts or DIG-labeled RNA complexed with N protein fractions from tospovirus-infected plants as described [12 (link)]. Five μg N proteins were mixed with 2 μg of DIG-labeled RNA probe in 10 μL volume and the mixtures were incubated for 10 min on ice to form N-RNA complexes. One μL of N-RNA mixtures was taken to incubate with 8 μL chromatography fractions. The mixtures were incubated for 10 min at room temperature to form N-RNA complexes. Cleavage reactions were incubated at 24°C for 60 minutes in presence of 15 U/mL RNase A inhibitor (TaKaRa, Japan) and 20 mM MgCl2. Control reactions were performed with elution buffer or with chromatography fractions from mock-inoculated plants. DIG-labeled RNA transcripts were resolved by electrophoresis on a 1% agarose gel and transferred to a Hybond-N+ membranes (GE Healthcare, UK) using the Bio-Rad semi-dry transfer unit (Bio-Rad, Hercules, CA). DIG-labelled signals on the blots were detected by AP-conjugated anti-digoxigenin antibodies and visualized by incubation in the presence of BCIP/NBT (Sangon Biotech, Shanghai, China) staining.
+ Open protocol
+ Expand
3

Recombinant Protein Expression Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
KOD-plus DNA polymerase was purchased from Toyobo (Osaka, Japan). Nickel–nitrilotriacetic acid resin was purchased from Bio-Rad (Hercules, CA, USA). RNase A inhibitor was purchased from Takara (Shiga, Japan). Oligodeoxyribonucleotides and oligoribonucleotides (Table S1) were synthesized by Invitrogen (Carlsbad, CA, USA) and Takara (Shiga, Japan), respectively. The expression vectors of pDEST17 (Invitrogen) and pET28-sumo were used throughout this study. E. coli strain DH5α was used in the gene cloning and Rosetta 2(DE3)pLysS (Novagen) strain was used to express recombinant protein. All other chemicals and reagents were of analytic grade.
+ Open protocol
+ Expand
4

Purification of P. furiosus Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNase A inhibitor was purchased from Takara (Dalian, China). KOD-plus DNA polymerase was purchased from Toyobo (Shanghai, China). Nickel-nitrilotriacetic acid resin was purchased from Bio-Rad (Shanghai, China). Oligodeoxyribonucleotides and oligoribonucleotides (Supplementary Table S1) were synthesized by Invitrogen (Shanghai, China) and Takara (Dalian, China), respectively. Expression vectors pDEST17 and pCDFDuet-1 were used throughout this study. Escherichia coli strain DH5α was used for cloning and Rosetta 2(DE3)pLysS strain was used to express P. furiosus protein. Mononucleotide CMP was purchased from Sigma. All other chemicals and reagents were of analytical grade.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!